PASITHEA THERAPEUTICS CORP. Adjustments to Additional Paid in Capital, Warrant Issued
PASITHEA THERAPEUTICS CORP. (KTTA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.38 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $1.38K.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $817.00, a 48.06% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $1.57K, a 99.87% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $2.36K.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $1.57K, a 80.00% decline from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $7.87K.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $680.00K, a 263.25% increase from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $187.20K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.38K 10-Q · filed 2026-08-14 | $2.19K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $817.00 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $1.57K 10-K · filed 2026-03-30 | |||
| 2025-03-31 | $1.57K 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $7.87K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $2.36K 10-Q · filed 2025-11-13 | $4.72K derived: sum of 2 quarters · filed 2025-11-13 | $5.51K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $2.36K 10-Q · filed 2025-11-13 | $3.15K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $787.00 10-Q · filed 2025-08-14 | |||
| 2022-12-31 | $680.00K 10-K · filed 2024-03-29 | |||
| 2022-06-30 | $350.72K 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $187.20K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $187.20K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |